Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $3.48 billion. The enterprise value is $2.64 billion.
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 246.95 million shares outstanding. The number of shares has increased by 29.36% in one year.
| Current Share Class | 211.44M |
| Shares Outstanding | 246.95M |
| Shares Change (YoY) | +29.36% |
| Shares Change (QoQ) | -20.02% |
| Owned by Insiders (%) | 2.94% |
| Owned by Institutions (%) | 73.17% |
| Float | 200.49M |
Valuation Ratios
The trailing PE ratio is 114.43 and the forward PE ratio is 29.80.
| PE Ratio | 114.43 |
| Forward PE | 29.80 |
| PS Ratio | 0.40 |
| Forward PS | 0.30 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 2.99 |
| P/FCF Ratio | 3.86 |
| P/OCF Ratio | 3.75 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 60.09, with an EV/FCF ratio of 2.93.
| EV / Earnings | 91.07 |
| EV / Sales | 0.32 |
| EV / EBITDA | 60.09 |
| EV / EBIT | 199.44 |
| EV / FCF | 2.93 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.31.
| Current Ratio | 0.80 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 6.20 |
| Debt / FCF | 0.40 |
| Interest Coverage | 0.55 |
Financial Efficiency
Return on equity (ROE) is 2.83% and return on invested capital (ROIC) is 0.59%.
| Return on Equity (ROE) | 2.83% |
| Return on Assets (ROA) | 0.21% |
| Return on Capital (ROIC) | 0.59% |
| Revenue Per Employee | $3.42M |
| Profits Per Employee | $12,062 |
| Employee Count | 2,400 |
| Asset Turnover | 2.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $6.90 million in taxes.
| Income Tax | 6.90M |
| Effective Tax Rate | 18.93% |
Stock Price Statistics
The stock price has increased by +75.91% in the last 52 weeks. The beta is 1.63, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | +75.91% |
| 50-Day Moving Average | 15.92 |
| 200-Day Moving Average | 17.35 |
| Relative Strength Index (RSI) | 42.72 |
| Average Volume (20 Days) | 4,414,174 |
Short Selling Information
The latest short interest is 16.93 million, so 6.86% of the outstanding shares have been sold short.
| Short Interest | 16.93M |
| Short Previous Month | 12.41M |
| Short % of Shares Out | 6.86% |
| Short % of Float | 8.44% |
| Short Ratio (days to cover) | 3.24 |
Income Statement
In the last 12 months, Oscar Health had revenue of $8.22 billion and earned $28.95 million in profits. Earnings per share was $0.12.
| Revenue | 8.22B |
| Gross Profit | 1.74B |
| Operating Income | 13.22M |
| Pretax Income | 23.89M |
| Net Income | 28.95M |
| EBITDA | 43.87M |
| EBIT | 13.22M |
| Earnings Per Share (EPS) | $0.12 |
Full Income StatementBalance Sheet
The company has $1.71 billion in cash and $362.90 million in debt, giving a net cash position of $843.25 million or $3.41 per share.
| Cash & Cash Equivalents | 1.71B |
| Total Debt | 362.90M |
| Net Cash | 843.25M |
| Net Cash Per Share | $3.41 |
| Equity (Book Value) | 1.17B |
| Book Value Per Share | 4.71 |
| Working Capital | -586.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $928.24 million and capital expenditures -$27.18 million, giving a free cash flow of $901.06 million.
| Operating Cash Flow | 928.24M |
| Capital Expenditures | -27.18M |
| Free Cash Flow | 901.06M |
| FCF Per Share | $3.65 |
Full Cash Flow StatementMargins
Gross margin is 21.21%, with operating and profit margins of 0.16% and 0.35%.
| Gross Margin | 21.21% |
| Operating Margin | 0.16% |
| Pretax Margin | 0.44% |
| Profit Margin | 0.35% |
| EBITDA Margin | 0.53% |
| EBIT Margin | 0.16% |
| FCF Margin | 10.97% |